Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract.

Lowering urinary oxalate excretion to decrease calcium oxalate stone disease.

Crystal agglomeration is a major element in calcium oxalate urinary stone formation.

The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract.

A huge bladder calcium oxalate stone.

Elemental Content of Calcium Oxalate Stones from a Canine Model of Urinary Stone Disease.

[A study of inhibitory effect of chondroitin polysulfate on stone formation of calcium oxalate].

A contribution to the formation mechanism of calcium oxalate urinary calculi. IV. Experimental investigations of the intrarenal crystallisation of calcium oxalate in rabbit.

Stone size limits the use of Hounsfield units for prediction of calcium oxalate stone composition.

Nanouric acid or nanocalcium phosphate as central nidus to induce calcium oxalate stone formation: a high-resolution transmission electron microscopy study on urinary nanocrystallites.

Effect of "Rosa Canina" infusion and magnesium on the urinary risk factors of calcium oxalate urolithiasis.

Uromucoids and urinary stone formation.

Calcium Oxalate Stone Fragment and Crystal Phagocytosis by Human Macrophages.

The paradoxical role of urinary macromolecules in the aggregation of calcium oxalate: a further plea to increase diuresis in stone metaphylaxis.

Evaluation of maternal urinary tract infection as a potential risk factor for neonatal urinary tract infection.

Should we modify the principles of risk evaluation and recurrence preventive treatment of patients with calcium oxalate stone disease in view of the etiologic importance of calcium phosphate?

Studying inhibition of calcium oxalate stone formation: an in vitro approach for screening hydrogen sulfide and its metabolites.

Endoscopic and histologic findings in a cohort of uric acid and calcium oxalate stone formers.

Prophylactic effects of quercetin and hyperoside in a calcium oxalate stone forming rat model.

Calcium intake and urinary stone disease.

Randall's plaque as the origin of calcium oxalate kidney stones.

Does the use of chitosan contribute to oxalate kidney stone formation?

The prevalence of calcified upper urinary tract stone disease in a random population--Cumbernauld Health Survey.

Stabilization of submicron calcium oxalate suspension by chondroitin sulfate C may be an efficient protection from stone formation.

Increased risk of urinary tract infection associated with the use of calcium supplements.

Suggest Documents

Lowering urinary oxalate excretion to decrease calcium oxalate stone disease.

Crystal agglomeration is a major element in calcium oxalate urinary stone formation.

The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract.

A huge bladder calcium oxalate stone.

Elemental Content of Calcium Oxalate Stones from a Canine Model of Urinary Stone Disease.

[A study of inhibitory effect of chondroitin polysulfate on stone formation of calcium oxalate].

A contribution to the formation mechanism of calcium oxalate urinary calculi. IV. Experimental investigations of the intrarenal crystallisation of calcium oxalate in rabbit.

Stone size limits the use of Hounsfield units for prediction of calcium oxalate stone composition.

Nanouric acid or nanocalcium phosphate as central nidus to induce calcium oxalate stone formation: a high-resolution transmission electron microscopy study on urinary nanocrystallites.

Effect of "Rosa Canina" infusion and magnesium on the urinary risk factors of calcium oxalate urolithiasis.

Uromucoids and urinary stone formation.

Calcium Oxalate Stone Fragment and Crystal Phagocytosis by Human Macrophages.

The paradoxical role of urinary macromolecules in the aggregation of calcium oxalate: a further plea to increase diuresis in stone metaphylaxis.

Evaluation of maternal urinary tract infection as a potential risk factor for neonatal urinary tract infection.

Should we modify the principles of risk evaluation and recurrence preventive treatment of patients with calcium oxalate stone disease in view of the etiologic importance of calcium phosphate?

Studying inhibition of calcium oxalate stone formation: an in vitro approach for screening hydrogen sulfide and its metabolites.

Endoscopic and histologic findings in a cohort of uric acid and calcium oxalate stone formers.

Prophylactic effects of quercetin and hyperoside in a calcium oxalate stone forming rat model.

Calcium intake and urinary stone disease.

Randall's plaque as the origin of calcium oxalate kidney stones.

Does the use of chitosan contribute to oxalate kidney stone formation?

The prevalence of calcified upper urinary tract stone disease in a random population--Cumbernauld Health Survey.

Stabilization of submicron calcium oxalate suspension by chondroitin sulfate C may be an efficient protection from stone formation.

Increased risk of urinary tract infection associated with the use of calcium supplements.

Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract.

Recommend Documents

Follow Us